CHE Stock Overview
Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 6/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
Chemed Corporation Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$617.95 |
| 52 Week High | US$654.62 |
| 52 Week Low | US$492.84 |
| Beta | 0.42 |
| 1 Month Change | -4.16% |
| 3 Month Change | 4.05% |
| 1 Year Change | 10.21% |
| 3 Year Change | 30.69% |
| 5 Year Change | 92.17% |
| Change since IPO | 5,362.54% |
Recent News & Updates
Recent updates
Chemed Corporation (NYSE:CHE) Full-Year Results: Here's What Analysts Are Forecasting For This Year
Mar 01
The Price Is Right For Chemed Corporation (NYSE:CHE)
Dec 30Chemed: Continues To Compound Shareholder Value At Double-Digit Returns
Nov 30Chemed (NYSE:CHE) Is Aiming To Keep Up Its Impressive Returns
Oct 26Chemed - Showcasing Why It's So Reliable
Aug 26Chemed: Still Bullish On Economic Characteristics, But Risks Shouldn't Be Overlooked
Aug 13Is Chemed Corporation (NYSE:CHE) Worth US$521 Based On Its Intrinsic Value?
Aug 01Capital Investments At Chemed (NYSE:CHE) Point To A Promising Future
Jul 14Chemed (NYSE:CHE) Has A Rock Solid Balance Sheet
Jun 07Chemed (NYSE:CHE) Is Aiming To Keep Up Its Impressive Returns
Apr 09Chemed Q4 2022 Earnings Preview
Feb 22Chemed Corporation: Long-Term Tailwinds, But Remains A Hold
Feb 14Is Chemed (NYSE:CHE) Using Too Much Debt?
Jan 05Here's What Chemed's (NYSE:CHE) Strong Returns On Capital Mean
Dec 17Chemed declares $0.38 dividend
Nov 04Chemed Q3 2022 Earnings Preview
Oct 28Does Chemed (NYSE:CHE) Have A Healthy Balance Sheet?
Oct 01Capital Investment Trends At Chemed (NYSE:CHE) Look Strong
Sep 16Buy Chemed To Reduce Equity Beta And Stabilize Portfolio Returns
Aug 26A Look At The Intrinsic Value Of Chemed Corporation (NYSE:CHE)
Aug 16Chemed declares $0.38 dividend
Aug 05Chemed Q2 results mixed, co increases top end of FY 2022 adj. EPS guidance range
Jul 27Is Chemed (NYSE:CHE) A Risky Investment?
Jun 29Chemed announces a five-year $550M amended and restated senior secured credit facility
Jun 29Returns on Capital Paint A Bright Future For Chemed (NYSE:CHE)
Jun 14Estimating The Intrinsic Value Of Chemed Corporation (NYSE:CHE)
May 14Is Chemed (NYSE:CHE) Using Too Much Debt?
Mar 25The Trend Of High Returns At Chemed (NYSE:CHE) Has Us Very Interested
Mar 04Shareholder Returns
| CHE | US Healthcare | US Market | |
|---|---|---|---|
| 7D | 2.3% | 2.0% | 1.2% |
| 1Y | 10.2% | 3.4% | 24.9% |
Return vs Industry: CHE exceeded the US Healthcare industry which returned 3.6% over the past year.
Return vs Market: CHE underperformed the US Market which returned 24.7% over the past year.
Price Volatility
| CHE volatility | |
|---|---|
| CHE Average Weekly Movement | 2.7% |
| Healthcare Industry Average Movement | 7.2% |
| Market Average Movement | 6.0% |
| 10% most volatile stocks in US Market | 16.6% |
| 10% least volatile stocks in US Market | 3.0% |
Stable Share Price: CHE has not had significant price volatility in the past 3 months.
Volatility Over Time: CHE's weekly volatility (3%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1970 | 15,087 | Kevin McNamara | www.chemed.com |
Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.
Chemed Corporation Fundamentals Summary
| CHE fundamental statistics | |
|---|---|
| Market cap | US$9.33b |
| Earnings (TTM) | US$272.51m |
| Revenue (TTM) | US$2.26b |
34.3x
P/E Ratio4.1x
P/S RatioIs CHE overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| CHE income statement (TTM) | |
|---|---|
| Revenue | US$2.26b |
| Cost of Revenue | US$1.47b |
| Gross Profit | US$798.82m |
| Other Expenses | US$526.31m |
| Earnings | US$272.51m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
Apr 25, 2024
| Earnings per share (EPS) | 18.00 |
| Gross Margin | 35.28% |
| Net Profit Margin | 12.03% |
| Debt/Equity Ratio | 0% |
How did CHE perform over the long term?
See historical performance and comparison